Synapse - Wassim Abida

Search Within

Wassim Abida

Results (154)

BET bromodomain inhibition blocks an AR-repressed, E2F1-activated treatment-emergent neuroendocrine prostate cancer lineage plasticity program

Journal Article

Kim, D. H.; Sun, D.; Storck, W. K.; Leng, K. W.; Jenkins, C.; Coleman, D. J.; Sampson, D.; Guan, X.; Kumaraswamy, A.; Rodansky, E. S.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms

Journal Article

Tukachinsky, H.; Madison, R. W.; Chung, J. H.; Gjoerup, O. V.; Severson, E. A.; Dennis, L.; Fendler, B. J.; Morley, S.; Zhong, L.; Graf, R. P.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Journal Article

Brannon, A. R.; Jayakumaran, G.; Diosdado, M.; Patel, J.; Razumova, A.; Hu, Y.; Meng, F.; Haque, M.; Sadowska, J.; Murphy, B. J.; more...
Nature Communications (2021)

Fulltext@MSK | Save

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Journal Article

Tsui, D. W. Y.; Cheng, M. L.; Shady, M.; Yang, J. L.; Stephens, D.; Won, H.; Srinivasan, P.; Huberman, K.; Meng, F.; Jing, X.; more...
Genome Medicine (2021)

Fulltext@MSK | Save

Characterization and management of ERK inhibitor associated dermatologic adverse events: Analysis from a nonrandomized trial of ulixertinib for advanced cancers

Journal Article

Wu, J.; Liu, D.; Offin, M.; Lezcano, C.; Torrisi, J. M.; Brownstein, S.; Hyman, D. M.; Gounder, M. M.; Abida, W.; Drilon, A.; more...
Investigational New Drugs (2021)

Fulltext@MSK | Save

Immunohistochemistry-based assessment of RB1 status in correlation with genomic sequencing and p16 expression in high-risk localized and metastatic castration-resistant prostate cancer

Meeting Abstract

Chen, J. F.; Gandhi, J.; Chang, J.; Gupta, S.; Abida, W.; Sarungbam, J.; Sirintrapun, S. J.; Chen, Y. B.; Al-Ahmadie, H.; Fine, S.; more...
Modern Pathology (2021)

Fulltext@MSK | Save

Immunohistochemistry-based assessment of RB1 status in correlation with genomic sequencing and p16 expression in high-risk localized and metastatic castration-resistant prostate cancer

Meeting Abstract

Chen, J. F.; Gandhi, J.; Chang, J.; Gupta, S.; Abida, W.; Sarungbam, J.; Sirintrapun, S. J.; Chen, Y. B.; Al-Ahmadie, H.; Fine, S.; more...
Laboratory Investigation (2021)

Fulltext@MSK | Save

Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer to identify targetable BRCA alterations and AR resistance mechanisms

Meeting Abstract

Tukachinsky, H.; Madison, R.; Chung, J.; Dennis, L.; Fendler, B.; Morley, S.; Zhong, L.; Graf, R.; Ross, J. S.; Alexander, B. M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

PLANETTE: A modular phase IIa multicenter open-label study evaluating the ATR inhibitor ceralasertib (AZD6738) in ATM mutant advanced solid tumors

Meeting Abstract

Abida, W.; Sanay, E.; Lukashchuk, N.; Pierce, A.; de Graaf, W.; Lau, A.; Ros, V. R.; Kurian, N.; Parr, G.; LoembE, B.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Association of co-occurring gene alterations and clinical activity of rucaparib in patients with BRCA1 or BRCA2 mutated (BRCA plus ) metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Abida, W.; Patnaik, A.; Campbell, D.; Shapiro, J. D.; Bryce, A. H.; McDermott, R. S.; Sautois, B.; Vogelzang, N. J.; Bambury, R. M.; Voog, E.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save